Eton Pharmaceuticals ETON
NASDAQ ETON
$50.18 +0.96 (+1.95%)
As of: Oct 20, 2026 · 3:59 PM EDT

Eton Pharmaceuticals (ETON) Long-Term Debt Repayments (2022 - 2024)

Updated

Eton Pharmaceuticals' Long-Term Debt Repayments came in at $1.16 million for FY2024, unchanged from $1.16 million in FY2023.

Analysis

Eton Pharmaceuticals (ETON) Long-Term Debt Repayments (2022 - 2024) Analysis & Trends

Going back to FY2021, Eton Pharmaceuticals' Long-Term Debt Repayments data covers 4 years.

  • Long-Term Debt Repayments carries a three-year compound annual growth rate of 97.5% (FY2021 to FY2024).
  • Per Business Quant, earlier years put Long-Term Debt Repayments at $1.16 million in FY2023 (+200.0%), $385,000 in FY2022 (+156.7%) and $150,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 1.00 Mn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 2.00 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 2.46 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 17.00 Mn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 Eton Pharmaceuticals 1.39 Bn 1.27 Bn 25.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 385,000.00
Jun 30, 2024 385,000.00
Mar 31, 2024 385,000.00
Dec 31, 2023 385,000.00
Sep 30, 2023 385,000.00
Jun 30, 2023 385,000.00
Mar 31, 2022 385,000.00
API Access

Eton Pharmaceuticals Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=ETON&period=max&api_key=YOUR_API_KEY